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Supplementary Materials 
 
method S1. Calculation of the focal spot size of TRUE and conventional focusing. 
To calculate the focal spot size of TRUE focusing from the images captured with the observation camera 
(Camera2 in fig. S1), the image was first cropped to a region (82 × 82 pixels) surrounding the focus 
profile, and was low-pass filtered by a 3 × 3 averaging filter to smooth the speckle. Then, the focus 
profile was fit using a 2D Gaussian function     2 2 20 0( , ) exp ( ) 2f x y A x x y y B        , where A, B, 
x0, y0,   are the fitting parameters. The full width at half maximum (FWHM) focal spot size was 
obtained by FWHM = 2 2ln 2 . The focal spot size of the conventional focusing was calculated in a 
similar way. However, since the focal spot size was much larger than that of TRUE focusing, the fitting 
was applied to a region composed of 1040 × 1392 pixels. 
 
method S2. Viral injection surgery. 
Mice were anesthetized with an isoflurane gas/carbogen mixture and placed to a stereotaxic frame (David 
Kopf Instruments, CA, USA). After sterilizing the skin with chlorohexidine, a midline incision was made 
with a sterile scalpel, the skull surface was cleaned with autoclaved cotton swabs, and the bregma and 
lambda were identified and leveled to be on the same z-axis. AAV-DJ-CaMKII-bReaChES-TS-YFP (500 
nL) was injected into the prelimbic cortex (AP + 1.65 mm, ML ± 0.2 mm, DV − 2.25 mm) using a blunt 
35-gauge microinjection needle within a 10 µL microsyringe (NanoFil, World Precision Instruments, FL, 
USA), which was controlled by a microsyringe pump (UMP3, World Precision Instruments) connected to 
a controller (Micro4, World Precision Instruments). Following injection, the needle/syringe was held in 
the same location for an additional 10 min to allow further diffusion. To prevent potential backflow, the 
needle/syringe was slowly withdrawn over approximately 10 min. After infusion, the scalp was sutured 
and the mouse was returned to the vivarium for post-operative recovery. Animal husbandry and all 
experimental procedures involving animal subjects were approved by the Institutional Animal Care and 
Use Committee (IACUC) and by the Office of Laboratory Animal Resources at the California Institute of 
Technology under IACUC protocol 1650. 
 
method S3. Electrophysiological recordings. 
Mice expressing CaMKII-bReaChES-TS-YFP were euthanized with carbon dioxide and transcardially 
perfused with ice-cold sucrose-based cutting solution saturated with 95% O2/5% CO2 (carbogen) that 
contained (mM) 85 NaCl, 75 sucrose, 2.5 KCl, 1.25 NaH2PO4, 4.0 MgCl2, 0.5 CaCl2, 24 NaHCO3 and 25 
glucose. The brain was removed and 300–800 μm thick coronal slices that contained the mPFC were 
prepared in oxygenated cutting solution using a vibratome (VT-1200, Leica Biosystems, IL, USA). Slices 
were recovered at 32°C for one hour prior to recording in carbogenated ACSF containing (mM): 125 
NaCl, 2.5 KCl, 1.2 NaH2PO4, 1.2 MgCl2, 2.4 CaCl2, 26 NaHCO3, and 11 glucose. Slices were transferred 
to the recording chamber and perfused (1.5 – 2.0 mL/min) with carbogen-saturated ACSF at 32 ± 0.5°C. 
Whole-cell patch clamp recordings were obtained using a Heka EPC 10 USB amplifier/digitizer (Heka 
Electronik, Germany) with data sampled at 10 kHz and filtered at 2 kHz. Patch electrodes had resistance 
of 4 – 8 MΩ and were filled with a potassium gluconate intrapipette solution (mM): 135 K gluconate, 5 
KCl, 5 EGTA, 0.5 CaCl2, 10 HEPES, 2 Mg-ATP, and 0.1 GTP.  
method S4. Daily alignment procedure. 
Before operation each day, the system was tuned to maintain optimal performance of the digital optical 
phase conjugation (DOPC) system by ensuring fine pixel-to-pixel alignment between the camera and the 
SLM. This procedure was conducted using the quality assurance (QA) arm of the system by opening 
shutters SH1 and SH2 as shown in fig. S1. The following steps were performed for the daily alignment. 
1. Playback beam normal to SLM. To ensure the SLM was perpendicular to the sample and 
playback beam (S/PB), we enabled the flip mirror FM and tilted the SLM to maximize the 
intensity measured by the QA photodiode (PD2).  
2. Record and playback a scattering field from QA path for DOPC loop B. We disabled flip 
mirror FM and optimized the alignment of DOPC loop B, which was enabled by setting the 
shutters BSS2 and BSS3 (fig. S1B). This allows the QA light beam to interfere with the reference 
beam (R), so the phase map of the scattered light could be measured using four-step phase-
shifting holography. After measuring the phase map, the conjugate phase map was displayed on 
the SLM, so the playback beam would propagate through the scattering medium (SM) and the 
single mode fiber (SF2) to reach PD2. The single mode fiber enables higher quality correction 
than previous quality assurance systems which use a camera to monitor the phase conjugation 
quality. 
3. Digitally search for tilt and shift misalignment (loop B). To assess the respective contributions 
of the shift and tilt misalignment between the camera and the SLM, the phase conjugate solution 
was digitally shifted and tilted while monitoring the intensity of PD2. This allows the 
misalignment to be mapped out before physically correcting the misalignment. Although we can 
digitally correct for the shift and tilt, we prefer to correct these parameters physically to reduce 
the computational time and improve the system performance during TRUE focusing operation. 
4. Physically correct for the tilt and shift misalignment (loop B). The tilt misalignment was 
corrected by tilting mirror M10 to maximize the signal captured by PD2. Similarly, the shift 
misalignment was corrected by translating the SLM in plane to maximize the detected signal on 
PD2.  
5. Aberration correction (loop B). The aberration of the SLM, the playback (PB) beam, and the 
associated optics in the light-path were digitally corrected by adding a compensation phase map 
determined using a series of Walsh-Hadamard patterns (76). The compensation map was saved 
for later use during the TRUE focusing procedure. 
6. Aberration correction for the CW laser. Since loop B was also used for the continuous-wave 
playback beam, a compensation phase map for this beam was measured as well. In this case, we 
switched the playback beam from the PW laser to the CW laser by switching the shutter BSS1. 
7. Alignment for DOPC loop A. The PW laser was enabled again by flipping shutter BSS1. DOPC 
loop A was also enabled by flipping shutters BSS2 and BSS3. Steps 2 to 5 were repeated to align 
DOPC loop A. Since loop A travels a different optical path, the physical tilt and shift correction is 
distinct from that of loop B. For loop A we corrected the tilt misalignment by tilting beamsplitter 
BS4 and the shift misalignment by simultaneously tilting beamsplitters BS8 and BS4.  
 
fig. S1. Setup. (A and B) Schematic of the setup for DOPC Loop A and Loop B. (C) The physiological 
setup (the A-A section in A and B) running in the neuron observation and patching mode. (D) The 
physiological setup running in the neuron stimulation mode. Abbreviations: ACSF, artificial 
cerebrospinal fluid; AOM, acousto-optic modulator; BB, beam block; BS, beamsplitter; BSS, beam 
selecting shutter; CL, camera lens; CP, chopper; CW laser, continuous-wave laser; DL, delay line; FM, 
flip mirror; HWP, half-wave plate; L, lens; LS, light source; M, mirror; MF, multi-mode fiber; ND, 
neutral-density filter; NP, Nomarski prism; OI, optical isolator; P, polarizer; PB, playback beam; PBS, 
polarizing beamsplitter; PD, photodiode; PH, pinhole; PN, plane; PP, pipette; QA, quality assurance; R, 
reference beam; S, sample beam; SC, sample chamber; SF, single-mode fiber; SH, optical shutter; SLM, 
spatial light modulator; SM, scattering medium; TS, tissue slice; UST, ultrasonic transducer; ZB, zeroth-
order block (a black 100 µm-diameter disk printed on a transparency). 
 
 fig. S2. Electrical signal flow diagram. The experiment can be divided into two phases. In the first phase, 
the TRUE focusing system searches for the wavefront solution using a pulsed-wave (PW) laser. After that, 
we switch to a continuous-wave (CW) laser by controlling the shutters using software triggers. To obtain 
a correct wavefront solution, we implement nine iterations of the TRUE focusing process by switching 
the shutters that select between DOPC loop A and B. In each DOPC loop, a four-step phase-shifting 
holography approach is used to measure the optical field of the ultrasound modulated light. In this case, 
an arbitrary function generator (AFG1) is used to synchronize the camera and the phase of the reference 
beam. The frequency of the reference beam is shifted by 50.020 MHz by AFG2. The reference beam 
shares a clock with the ultrasound pulses and lasers pulses, both of which are triggered at 40 kHz. A 7.46 
μs delay is used to compensate for the propagation time of the ultrasound wave traveling to the ultrasound 
focus. Abbreviations: AFG, arbitrary function generator; AMP, amplifier; AOM, acousto-optic modulator; 
DG, delay generator; UST, ultrasound transducer. 
  
fig. S3. Ultrasound pulse-echo image of the tip of the glass pipette electrode. To focus ultrasound to 
the targeted neuron that is patch-clamped by the glass pipette, the ultrasound transducer is scanned to 
image the pipette tip in pulse-echo mode. The echo is recorded at each scanning position to form an 
image of the tip where the neuron is located. The transducer is then moved to that location so that the 





fig. S4. Electrophysiological photocurrent traces from neurons in 500- and 300-μm-thick acute 
brain slices. TRUE focusing enables photocurrent enhancement at depths of 500 µm (A) and 300 µm (B) 
in addition to the 800 µm thickness shown in the main text. 
 fig. S5. Electrophysiological photocurrent and membrane voltage traces comparing ultrasound on 
and off conditions. (A) Photocurrent traces when performing the TRUE focusing procedure with the 
ultrasound on and off. When the ultrasound is on, a phase map is measured which enables light to be 
focused to the location of the ultrasound focus and the neuron cell body. In contrast, when the ultrasound 
is disabled by turning off its driving amplifier, an incorrect phase map is measured so that the playback 
beam is not focused onto the neuron. As a result, we see a decrease in the amplitude of the photocurrent. 
(B) Membrane voltage traces when performing the TRUE focusing procedure with the ultrasound on and 
off. When the ultrasound is on, the playback beam is focused onto the neuron and elicit action potentials. 
In comparison, when the ultrasound is off, light is not focused onto the neuron and therefore no action 
potentials are elicited. It should be noted that the photocurrent and membrane voltage are lower with 
ultrasound off than those with ultrasound on followed by a shifted TRUE phase map displayed on the 
SLM (Fig. 3) which leads to an artificially increased photocurrent enhancement since the overall energy 
in the “US OFF” condition is lower than in the “No Shaping” condition. This is because the random phase 
map measured with ultrasound off has a higher spatial frequency (1/pixel size) than that of a normal phase 
map, and these high frequency components are filtered out by the limited numerical aperture of the 
optical system. In contrast, the shifted phase pattern in the “No Shaping” condition does not change the 
spatial frequency distribution of the phase map measured with ultrasound on and therefore maintains the 
same background intensity level as the background of the TRUE focus. 
 
